The global head and neck cancer drugs market is estimated to be valued at US$ 1,851.2 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Head and neck cancer drugs are used for the treatment of head and neck cancer, which includes cancers of the mouth, throat, larynx, salivary glands, nose, and sinuses. These drugs play a crucial ... Read more
